Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0001209191-23-022988

EVP, Global Sales & Marketing sold 9,973 shares at an average $5.02 ($50,084)

  • EVP, Global Sales & Marketing acquired 9,973 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ross Thomas M. · EVP, Global Sales & Marketing

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-31 Exercise or conversion : show line 1 in the form 10b5-1 +2,607 $2.14 $5,584 2,607 D
2023-03-31 Sale : show line 2 in the form 10b5-1 −2,607 $5.00 $13,035 0 D
2023-04-03 Exercise or conversion : show line 3 in the form 10b5-1 +100 $2.14 $214 100 D
2023-04-03 Sale : show line 4 in the form 10b5-1 −100 $5.01 $501 0 D
2023-04-04 Exercise or conversion : show line 5 in the form 10b5-1 +7,266 $2.14 $15,564 7,266 D
2023-04-04 Sale : show line 6 in the form 10b5-1 −7,266 $5.03 $36,548 0 D
Open-market sales · 9,973 sh · avg $5.02 · $50,084

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-03-31 Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (right to buy) −2,607 69,528 D
2023-04-03 Exercise or conversion : show line 8 in the form 10b5-1 Employee Stock Option (right to buy) −100 69,428 D
2023-04-04 Exercise or conversion : show line 9 in the form 10b5-1 Employee Stock Option (right to buy) −7,266 62,162 D
Loading xslF345X04/doc4.xml…